JOSE ANGEL
BEREZO GARCIA
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (19)
2023
-
Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study
The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441
-
Programa de optimización del uso de antimicrobianos en un Servicio de Medicina Intensiva: análisis retrospectivo observacional de los resultados 15 meses después de su implementación
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 477-485
2022
-
Determinants of mortality in cancer patients with unscheduled admission to the Intensive Care Unit: A prospective multicenter study
Medicina Intensiva, Vol. 46, Núm. 12, pp. 669-679
-
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients
Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study
Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1
2020
-
Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events
Internal and Emergency Medicine, Vol. 15, Núm. 8, pp. 1533-1544
-
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19
Critical Care, Vol. 24, Núm. 1
2018
-
Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study
Critical Care, Vol. 22, Núm. 1
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2014
-
Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma
Journal of Pain and Symptom Management
-
IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
Journal of Clinical Virology
2013
-
IgM levels in plasma predict outcome in severe pandemic influenza
Journal of Clinical Virology, Vol. 58, Núm. 3, pp. 564-567
2012
-
Antibiotic prescription patterns in the empiric therapy of severe sepsis: Combination of antimicrobials with different mechanisms of action reduces mortality
Critical Care, Vol. 16, Núm. 6
-
Viral infection is associated with an increased proinflammatory response in chronic obstructive pulmonary disease
Viral Immunology, Vol. 25, Núm. 4, pp. 249-253
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386
-
Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain
Respirology, Vol. 16, Núm. 1, pp. 78-85